Intra‐Aortic Balloon Pump Use in Acute Coronary Syndrome Without Cardiogenic Shock: Association With Mortality in the CCC‐ACS Cohort
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70257 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Chu Fan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing…. Hauptthemen laut MEDLINE: Intra-Aortic Balloon Pumping, Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: The CCC project is a program of the AHA and the CSC. The AHA has been funded byPfizer and AstraZeneca for quality improvement initiative through an independent….
Abstract (Originalsprache)
Background
The role of intra‐aortic balloon pump (IABP) in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) without cardiogenic shock remains controversial.
Aims
To assess the association between IABP use and in‐hospital mortality in this population and to identify high‐risk subgroups.
Methods
This multicenter retrospective study analyzed data from the CCC‐ACS Project. Propensity score matching (PSM) and multivariable logistic regression were performed to adjust for confounders. Subgroup analyses identified patients groups at greater risk. A supplementary meta‐analysis was conducted to reflect existing uncertainty in the broader literature.
Results
Among 32,863 ACS patients, 1,127 (3.4%) received IABP. In the propensity‐matched cohort, IABP use was associated with higher in‐hospital mortality (adjusted OR: 2.56, 95% CI: 1.30–5.04, p = 0.006). The risk was more pronounced in patients with ST‐segment elevation myocardial infarction, heart failure, reduced left ventricular ejection fraction, and renal impairment. The meta‐analysis of 10 studies showed no significant association between IABP use and mortality (RR = 1.06, 95% CI: 0.79–1.42, p = 0.70).
Conclusions
IABP use in ACS patients without cardiogenic shock was associated with increased in‐hospital mortality, particularly among high‐risk subgroups. Careful patient selection is warranted, and further research is needed to refine its clinical indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
ORCID-Profile: Chu Fan, Shen Wang, Fadong Li, Xiaofan Wu
Förderung
- The CCC project is a program of the AHA and the CSC. The AHA has been funded byPfizer and AstraZeneca for quality improvement initiative through an independent…
Zitieren
APA
Fan, C., Zou, Y., Chen, L., Wang, Y., Pang, S., Wang, S., Shi, B., Qin, Z., Li, F., Zhao, W., Guo, P., Zhang, L., & Wu, X. (2026). Intra‐Aortic Balloon Pump Use in Acute Coronary Syndrome Without Cardiogenic Shock: Association With Mortality in the CCC‐ACS Cohort. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70257
Vancouver
Fan C, Zou Y, Chen L, Wang Y, Pang S, Wang S, et al. Intra‐Aortic Balloon Pump Use in Acute Coronary Syndrome Without Cardiogenic Shock: Association With Mortality in the CCC‐ACS Cohort. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70257
BibTeX
@article{Fan2026,
author = {Fan, Chu and Zou, Yi and Chen, Liangguo and Wang, Yue and Pang, Shuo and Wang, Shen and Shi, Boqun and Qin, Zhenbai and Li, Fadong and Zhao, Wenxin and Guo, Pengrong and Zhang, Leli and Wu, Xiaofan},
title = {Intra‐Aortic Balloon Pump Use in Acute Coronary Syndrome Without Cardiogenic Shock: Association With Mortality in the CCC‐ACS Cohort},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70257}
}
EUVIMED